Embecta Corp (NASDAQ: EMBC) kicked off on Monday, up 5.02% from the previous trading day, before settling in for the closing price of $9.56. Over the past 52 weeks, EMBC has traded in a range of $9.56-$21.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 0.25% over the last five years. While this was happening, its average annual earnings per share was recorded 16.16%. With a float of $54.38 million, this company’s outstanding shares have now reached $58.33 million.
The firm has a total of 2100 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.46%, operating margin of 16.09%, and the pretax margin is 5.1%.
Embecta Corp (EMBC) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Embecta Corp is 6.95%, while institutional ownership is 93.71%. The most recent insider transaction that took place on May 23 ’25, was worth 105,995. In this transaction Director of this company bought 10,000 shares at a rate of $10.60, taking the stock ownership to the 86,681 shares. Before that another transaction happened on Feb 25 ’25, when Company’s Director bought 13,000 for $13.67, making the entire transaction worth $177,646. This insider now owns 76,681 shares in total.
Embecta Corp (EMBC) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 16.16% per share during the next fiscal year.
Embecta Corp (NASDAQ: EMBC) Trading Performance Indicators
Take a look at Embecta Corp’s (EMBC) current performance indicators. Last quarter, stock had a quick ratio of 1.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.54. Likewise, its price to free cash flow for the trailing twelve months is 14.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.91, a number that is poised to hit 0.77 in the next quarter and is forecasted to reach 2.86 in one year’s time.
Technical Analysis of Embecta Corp (EMBC)
Analysing the last 5-days average volume posted by the [Embecta Corp, EMBC], we can find that recorded value of 0.69 million was better than the volume posted last year of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 24.53%. Additionally, its Average True Range was 0.57.
During the past 100 days, Embecta Corp’s (EMBC) raw stochastic average was set at 5.40%, which indicates a significant decrease from 33.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.58% in the past 14 days, which was lower than the 60.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.44, while its 200-day Moving Average is $14.88. Now, the first resistance to watch is $10.22. This is followed by the second major resistance level at $10.41. The third major resistance level sits at $10.77. If the price goes on to break the first support level at $9.67, it is likely to go to the next support level at $9.31. Should the price break the second support level, the third support level stands at $9.12.
Embecta Corp (NASDAQ: EMBC) Key Stats
The company with the Market Capitalisation of 586.76 million has total of 58,443K Shares Outstanding. Its annual sales at the moment are 1,123 M in contrast with the sum of 78,300 K annual income. Company’s last quarter sales were recorded 259,000 K and last quarter income was 23,500 K.
